Back to search results

Observational Study of Drug Levels in Children

This study is looking at how the bodies of children with Pediatric ALL (Acute Lymphoblastic Leukemia) process common medications. Researchers are collecting information on standard-of-care drugs like dexmedetomidine, bosentan, furosemide, and many others, as prescribed by their doctors. The goal is to understand how much of these drugs are in a child's system over time (called Area Under the Curve or AUC). Children up to 20 years old who are already receiving these medications can join. This is an observational study, meaning researchers are just watching and collecting data, not giving new treatments. The study aims to enroll 200 participants, but its current status is unclear.

Study design
This is an observational study involving up to 200 participants. Researchers will collect data on children receiving standard medical care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Data will be collected throughout a hospital or outpatient stay, up to 90 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03481881

Pharmacokinetics of Drugs Administered to Children

Recruiting
Not specifiedAges 0–20Observational
Duke University
~200 participants
Updated 2026-01-07 on ClinicalTrials.gov
What's tested:Standard of care drug

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Area under the curve (AUC)
Measured over Data will be collected throughout the hospital or outpatient stay up to 90 days

Conditions

Pediatric ALL

Explore related trials

Acute Lymphoblastic Leukemia

NCT03481881

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Duke University

    Durham, North Carolinastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Rachel G Greenberg, MD
[email protected]
9196684725
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Children (\< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver

Exclusion

Failure to obtain consent/assent (as indicated)

What this trial measures

  • Area under the curve (AUC)Data will be collected throughout the hospital or outpatient stay up to 90 days